Jinfeng Xiang
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
ABO Blood Group and the Risk of Pancreatic Neoplasms in Chinese Han Population: A Study at Shanghai Pancreatic Cancer Institute.
Journal: Pancreas
Published: October 15, 2019
dCK negatively regulates the NRF2/ARE axis and ROS production in pancreatic cancer.
Journal: Cell proliferation
Published: November 27, 2017
Diagnostic Accuracy of a CA125-Based Biomarker Panel in Patients with Pancreatic Cancer: A Systematic Review and Meta-Analysis.
Journal: Journal of Cancer
Published: December 24, 2016
A new facet of NDRG1 in pancreatic ductal adenocarcinoma: Suppression of glycolytic metabolism.
Journal: International journal of oncology
Published: December 20, 2016
ARF6, induced by mutant Kras, promotes proliferation and Warburg effect in pancreatic cancer.
Journal: Cancer letters
Published: October 25, 2016
Oncogenic KRAS Targets MUC16/CA125 in Pancreatic Ductal Adenocarcinoma.
Journal: Molecular cancer research : MCR
Published: September 01, 2016
Metabolic plasticity in heterogeneous pancreatic ductal adenocarcinoma.
Journal: Biochimica et biophysica acta
Published: June 29, 2016
Energy sources identify metabolic phenotypes in pancreatic cancer.
Journal: Acta biochimica et biophysica Sinica
Published: June 20, 2016
The clinical utility of CA125/MUC16 in pancreatic cancer: A consensus of diagnostic, prognostic and predictive updates by the Chinese Study Group for Pancreatic Cancer (CSPAC).
Journal: International journal of oncology
Published: November 20, 2015
Metabolic tumor burden: a new promising way to reach precise personalized therapy in PDAC.
Journal: Cancer letters
Published: December 15, 2014
Showing 1-12 of 12
Last Updated: 09/26/2026